Takamasa Katagiri Selected Research

Takamasa Katagiri Research Topics

13	Aplastic Anemia (Anemia, Hypoplastic) 11/2023 - 03/2011
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018 - 03/2010
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 03/2010
2	Bone Marrow Failure Disorders 12/2012 - 03/2011
2	Neoplasms (Cancer) 03/2010 - 11/2008
1	Massive Hepatic Necrosis 11/2023
1	Hepatitis 11/2023
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018
1	Pure Red-Cell Aplasia 04/2016
1	Chromosome Aberrations (Chromosome Abnormalities) 12/2012
1	Hematologic Neoplasms (Hematological Malignancy) 11/2008

6	Proteins (Proteins, Gene)FDA Link 11/2021 - 11/2008
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2023 - 04/2016
3	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 11/2021 - 03/2011
3	HLA-A Antigens (HLA-A)IBA 01/2021 - 11/2008
2	HLA-DR15 antigenIBA 10/2023 - 01/2022
2	HLA-DR Antigens (HLA-DR)IBA 10/2023 - 01/2022
2	AntigensIBA 03/2010 - 11/2008
1	GPI-Linked ProteinsIBA 11/2021
1	Nonsense Codon (Nonsense Mutation)IBA 01/2021
1	LigandsIBA 01/2020
1	Inositol (Myoinositol)IBA 01/2018
1	AutoantigensIBA 01/2017
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2016
1	HLA-B Antigens (HLA-B)IBA 01/2016
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2010
1	Peptides (Polypeptides)IBA 11/2008

1	Liver Transplantation 11/2023
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 11/2023
1	Therapeutics 01/2018
1	Immunotherapy 11/2008